BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 21981759)

  • 61. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma.
    Sgambato A; Camerini A; Genovese G; De Luca F; Viacava P; Migaldi M; Boninsegna A; Cecchi M; Sepich CA; Rossi G; Arena V; Cittadini A; Amoroso D
    Cancer Sci; 2010 Sep; 101(9):2080-6. PubMed ID: 20626751
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Loss of p27(Kip1) CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer.
    Pertia A; Nikoleishvili D; Trsintsadze O; Gogokhia N; Managadze L; Chkhotua A
    Int Urol Nephrol; 2007; 39(2):381-7. PubMed ID: 17310312
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker.
    Moon A; Park JY; Sung JY; Park YK; Kim YW
    Pathology; 2012 Oct; 44(6):534-9. PubMed ID: 22935977
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.
    Dagher J; Dugay F; Rioux-Leclercq N; Verhoest G; Oger E; Bensalah K; Cabillic F; Jouan F; Kammerer-Jacquet SF; Fergelot P; Vigneau C; Arlot-Bonnemains Y; Belaud-Rotureau MA
    Hum Pathol; 2014 Aug; 45(8):1639-46. PubMed ID: 24856572
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of an altered Wnt1/β-catenin expression on clinicopathology and prognosis in clear cell renal cell carcinoma.
    Kruck S; Eyrich C; Scharpf M; Sievert KD; Fend F; Stenzl A; Bedke J
    Int J Mol Sci; 2013 May; 14(6):10944-57. PubMed ID: 23708097
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
    Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
    Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis.
    Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
    Exp Eye Res; 2014 Jan; 118():46-52. PubMed ID: 24216315
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma.
    Gayed BA; Youssef RF; Bagrodia A; Darwish OM; Kapur P; Sagalowsky A; Lotan Y; Margulis V
    BJU Int; 2014 Apr; 113(4):668-73. PubMed ID: 23937277
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cumulative number of altered biomarkers in mammalian target of rapamycin pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma.
    Darwish OM; Kapur P; Youssef RF; Bagrodia A; Belsante M; Alhalabi F; Sagalowsky AI; Lotan Y; Margulis V
    Urology; 2013 Mar; 81(3):581-6. PubMed ID: 23290145
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Expression of cyclin D1 and p27kip1 in renal cell carcinoma and its significance].
    Ge JR; Ren GP; Yao HP
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 36(5):483-7. PubMed ID: 17924468
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Yuan J; Liu S; Yu Q; Lin Y; Bi Y; Wang Y; An R
    Acta Histochem; 2013 Jun; 115(5):470-4. PubMed ID: 23245688
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma.
    Zhuang Q; Qian X; Cao Y; Fan M; Xu X; He X
    J Int Med Res; 2014 Apr; 42(2):282-91. PubMed ID: 24514433
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma.
    Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G
    Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
    Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
    Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
    Pantuck AJ; Seligson DB; Klatte T; Yu H; Leppert JT; Moore L; O'Toole T; Gibbons J; Belldegrun AS; Figlin RA
    Cancer; 2007 Jun; 109(11):2257-67. PubMed ID: 17440983
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytoplasmic expression of p27(kip1) is associated with a favourable prognosis in colorectal cancer patients.
    Watson NF; Durrant LG; Scholefield JH; Madjd Z; Scrimgeour D; Spendlove I; Ellis IO; Patel PM
    World J Gastroenterol; 2006 Oct; 12(39):6299-304. PubMed ID: 17072952
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunoreactivity of p27(Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma.
    Pertia A; Nikoleishvili D; Trsintsadze O; Gogokhia N; Managadze L; Chkhotua A
    Int Urol Nephrol; 2009; 41(2):243-9. PubMed ID: 18679818
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma.
    Hatiboglu G; Pritsch M; Macher-Goeppinger S; Zöller M; Huber J; Haferkamp A; Pahernik S; Wagener N; Hohenfellner M
    Scand J Urol; 2013 Aug; 47(4):311-22. PubMed ID: 23140095
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma.
    Krabbe LM; Westerman ME; Bagrodia A; Gayed BA; Darwish OM; Haddad AQ; Khalil D; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    J Urol; 2014 Jun; 191(6):1671-7. PubMed ID: 24291548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.